The Plasma Fractionation Market Industry was valued at USD 27.1 billion in 2022 and is projected to reach USD 43.52 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.1% during the forecast period from 2023 to 2030.
Plasma fractionation refers to the process of separating plasma into its various components, such as albumin, immunoglobulins, and clotting factors. This market has witnessed significant growth in recent years, driven by the increasing demand for plasma-derived products in the treatment of various diseases and medical conditions.
The rising prevalence of chronic diseases, such as immune deficiencies, bleeding disorders, and liver diseases, has fueled the demand for plasma-derived therapies. Additionally, the growing geriatric population and advancements in healthcare infrastructure have further contributed to the market's expansion.
Furthermore, technological advancements in plasma fractionation techniques have enhanced the efficiency and safety of the process, thereby boosting market growth. The introduction of advanced filtration methods and improved purification techniques has led to the production of high-quality plasma-derived products, ensuring better patient outcomes.
Geographically, North America dominates the plasma fractionation market, owing to the presence of well-established healthcare infrastructure and a high demand for plasma-derived therapies. However, the Asia Pacific region is expected to witness substantial growth during the forecast period, driven by the increasing healthcare expenditure, rising awareness about plasma-derived products, and the growing prevalence of chronic diseases.
In conclusion, the plasma fractionation market is poised for significant growth in the coming years, driven by the increasing demand for plasma-derived therapies and advancements in technology. With a CAGR of 6.1% over the forecast period, this market presents lucrative opportunities for industry players to expand their presence and cater to the rising healthcare needs of the global population.
Get Sample Report @ https://www.snsinsider.com/sample-request/2992
KEY MARKET SEGMENTATION
By Product
- Albumin
- Von Willebrand Factor
- PCC
By Application
- Neurology
- Immunology
- Hematology
- Rheumatology
By End User
- Hospitals
- Clinics
- Clinical Research
Key players
The major key players are Bio Products Laboratory (BPL), Biotest AG, China Biologic Products Holdings, Inc., CSL Limited, Japan Blood Products Organisation, Kedrion S.p.A., LFB Group, Octapharma AG, Sanquin, Shanghai RAAS. And the final reports list additional participants..
Table of Contents
1.Introduction
2.Research Methodology
3.Market Dynamics
4.Impact Analysis
4.1COVID-19 Impact Analysis
4.2.Impact of Ukraine- Russia war
4.3.Impact of Ongoing Recession on Major Economies
5.Value Chain Analysis
6.Porter’s 5 Forces Model
7.PEST Analysis
8.Blood Group TypingMarket, By Product
9.Blood Group Typing Market, By Application
10.Blood Group Typing Market, By End User
11.Regional Analysis
12.Company Profile
13. Competitive Landscape
14. Use Case and Best Practices
15 .Conclusion
Other Trending Report
Tuberculosis (TB) Diagnostics Market Analysis
Blood Group Typing Market Analysis
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
Contact Us:
Akash Anand – Head of Business Development & Strategy
info@snsinsider.com
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)
Website: https://www.snsinsider.com